Elsevier and NESLi2 conclude major new agreement to provide online science journals
ScienceDirect Access for UK universities and research communities extended through 2008
Amsterdam, December 19, 2005 – The UK Joint Information Systems Committee (JISC) and Elsevier, part of the Reed Elsevier Group, today announced the conclusion of a new agreement as part of NESLi2, the national electronic journals initiative for the higher education and research communities in the United Kingdom.
The new two-year agreement, which begins in January 2006, provides the framework under which the UK’s universities and research communities will have electronic access to Elsevier’s scientific, technical and medical journals through the ScienceDirect platform. These include many of the most highly ranked and important journals in their respective fields.
Lorraine Estelle, JISC Collections Team Manager, said: “NESLi2 is the UK’s national initiative for the licensing of electronic journals on behalf of the higher and further education and research communities and provides an efficient, cost effective way to negotiate and disseminate offers to these communities. The JISC is delighted to have reached a NESLi2 agreement with Elsevier for its collection of electronic journals. The agreement is based on the NESLi2 Licence for Journals which ensures a consistent approach to access and use of these journals to allow teachers, learners and researchers to use them to their fullest potential in support of their activities.”
“We are very pleased to come to this agreement with JISC and to support the UK higher education and research community,” commented Frank Vrancken Peeters, Global Sales Director, Elsevier Science & Technology, “JISC's mission to enhance learning, teaching and research in the UK will be bolstered through the continued access to highly valued, peer-reviewed scientific and medical research content through ScienceDirect.”
NESLi2 was launched in June 2003 and covers subscription agreements for the years 2004 to 2006. It is the successor scheme to the original NESLI which ran from 1997-2002. NESLi2 has focused its discussions on ten scholarly publishers for 2004, following an extensive Serials Requirements Survey undertaken in 2002. An eleventh consortium of publishers was added when it became clear that the ALPSP Learned Journals Collection would be available for libraries to order for 2004. The negotiations were handled by Content Complete Ltd on behalf of JISC.
The JISC is a joint committee of the UK further and higher education funding bodies, and is responsible for supporting the innovative use of information and communication technology (ICT) to support learning, teaching, and research. It is best known for providing the SuperJANET network, a range of advice and support services, and a portfolio of high-quality resources. Information about the JISC, its services and programmes can be found at http://www.jisc.ac.uk/ Contact Philip Pothen on +44 (0)20 7848 2935, email email@example.com
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
+31 20 485 2025